SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-05-005972
Filing Date
2005-05-13
Accepted
2005-05-13 16:21:32
Documents
10
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a08981e10vq.htm 10-Q 379264
2 EXHIBIT 10.1 a08981exv10w1.txt EX-10.1 24441
3 EXHIBIT 10.2 a08981exv10w2.txt EX-10.2 10778
4 EXHIBIT 10.3 a08981exv10w3.txt EX-10.3 26511
5 EXHIBIT 15.1 a08981exv15w1.txt EX-15.1 1424
6 EXHIBIT 31.1 a08981exv31w1.txt EX-31.1 3979
7 EHXIBIT 31.2 a08981exv31w2.txt EX-31.2 3975
8 EXHIBIT 32.1 a08981exv32w1.txt EX-32.1 1288
9 EXHIBIT 32.2 a08981exv32w2.txt EX-32.2 1283
10 GRAPHIC a08981a0898100.gif GRAPHIC 17844
  Complete submission text file 0000950137-05-005972.txt   479221
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 05829628
SIC: 2834 Pharmaceutical Preparations